PEGHIN, MADDALENA
 Distribuzione geografica
Continente #
EU - Europa 2.793
NA - Nord America 1.152
AS - Asia 168
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
SA - Sud America 1
Totale 4.126
Nazione #
IT - Italia 2.215
US - Stati Uniti d'America 1.150
IE - Irlanda 241
SE - Svezia 139
GB - Regno Unito 79
SG - Singapore 63
FI - Finlandia 57
CN - Cina 36
IN - India 26
JP - Giappone 18
DE - Germania 16
CZ - Repubblica Ceca 15
VN - Vietnam 14
UA - Ucraina 12
NL - Olanda 9
EU - Europa 4
EG - Egitto 3
FR - Francia 3
HK - Hong Kong 3
TR - Turchia 3
DZ - Algeria 2
ID - Indonesia 2
MX - Messico 2
PL - Polonia 2
SY - Repubblica araba siriana 2
UG - Uganda 2
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
ES - Italia 1
LT - Lituania 1
PK - Pakistan 1
PT - Portogallo 1
VE - Venezuela 1
Totale 4.126
Città #
Milan 1.674
Dublin 241
Ashburn 215
Rome 126
Boardman 116
Nyköping 114
Chandler 101
Princeton 96
Chicago 66
Singapore 63
Washington 60
Helsinki 50
Fairfield 38
London 28
Dallas 27
Ogden 24
Pune 24
Seattle 21
Santa Clara 18
Tokyo 18
Brno 14
Los Angeles 14
San Diego 14
Kilburn 13
Assago 12
Dong Ket 12
Houston 12
Jacksonville 9
Cambridge 8
Woodbridge 8
Lappeenranta 7
Hounslow 6
Munich 6
New Bedfont 6
Acton 5
Bologna 5
Chiswick 5
Amsterdam 4
Ann Arbor 4
Pisa 4
Redmond 4
Wilmington 4
Berlin 3
Cairo 3
Caserta 3
New York 3
Prescot 3
Southwark 3
Varese 3
Wandsworth 3
Aberdeen 2
Altamura 2
Belluno 2
Cologne 2
Damascus 2
Dearborn 2
Genoa 2
Hong Kong 2
Jijelli 2
Marcallo con Casone 2
Mexico City 2
Naples 2
Novara 2
Paris 2
Romola 2
San Michele al Tagliamento 2
Treviso 2
Abbasanta 1
Arezzo 1
Beijing 1
Changchun 1
Changsha 1
Chennai 1
Como 1
Council Bluffs 1
Fayetteville 1
Ferrara di Monte Baldo 1
Florence 1
Guangzhou 1
Hefei 1
Hollywood 1
Islington 1
Istanbul 1
Izmir 1
Jakarta 1
Kaifeng 1
Kunming 1
Lamezia Terme 1
Lanzhou 1
Magnago 1
Maia 1
Melegnano 1
Middenmeer 1
Mineral Ridge 1
Modena 1
Nanjing 1
Nanyang 1
Newark 1
Ningbo 1
Norwalk 1
Totale 3.387
Nome #
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 110
Causes of Death in a Contemporary Cohort of Patients with Invasive Aspergillosis 57
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience 55
Perioperative Antibiotic Stewardship in the Organ Transplant Setting 53
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients 53
Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality 53
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study 52
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study 52
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant 52
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 51
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study 51
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection After Liver Transplantation: A Multinational Cohort Study 50
Neuroinvasive West Nile Infection with an Unusual Clinical Presentation: A Single-Center Case Series 50
Saprochaete capitata aortitis in an immunocomopetent patient after myocardial revascularization 49
10years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation 49
Donor-derived bacterial infections in lung transplant recipients in the era of multidrug resistance 49
Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination 48
A look at clinical trial design for new antimicrobials for the adult population 48
Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review 47
Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Active Agents for the Treatment of Bacteremia and Nosocomial Pneumonia due to Drug-Resistant Pseudomonas aeruginosa 46
Clinical characteristics and outcome of 125 polymicrobial bloodstream infections in hematological patients: an 11-year epidemiologic survey 46
SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients 45
Epidemiology and Immediate Indirect Effects of Respiratory Viruses in Lung Transplant Recipients: A 5-Year Prospective Study 45
Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections 45
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis 45
Clinical efficacy of beta-lactam/beta-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR) 44
Relationship between cytokine release and stress hyperglycemia in patients hospitalized with COVID-19 infection 44
Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains 43
Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study 43
Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa 43
How to manage KPC infections 42
Community-acquired pneumonia: is less more? 42
CARVs, CLAD, and CMV: A Call for Heightened Awareness in Lung Transplant Recipients 42
Risk scores and surgery for infective endocarditis: in search of a good predictive score 42
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality 42
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 42
Mycobacterium chimaera infection after cardiac surgery: Catastrophic effects of delayed diagnosis 41
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians? 41
Fungal Endogenous Endophthalmitis Secondary to Magnusiomyces capitatus 41
Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients 40
Salvage heart transplantation for Mycoplasma hominis prosthetic valve endocarditis: A case report and review of the literature 40
Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant/extensively drug-resistant/pandrug-resistant bacteria 40
The current treatment landscape: candidiasis 40
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project 40
Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy 40
Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe 40
When to switch to an oral treatment and/or to discharge a patient with skin and soft tissue infections 40
Successful JC virus-targeted T-cell therapy for progressive multifocal leukoencephalopathy in a lung transplant recipient 39
Prevention and Treatment of Respiratory Virus Infection 39
Optimal Management of Complicated Infections in the Pediatric Patient: The Role and Utility of Ceftazidime/Avibactam 39
Clinical presentation and immunological features of Post-Malaria Neurologic Syndrome: a case report and review of literature 39
The changing epidemiology of spinal tuberculosis: the influence of international immigration in Catalonia, 1993-2014 39
Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients 39
Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactam 39
Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis? 39
Environmental variables associated with an increased risk of invasive aspergillosis 39
Efficacy of beta-Lactam/beta-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia 39
Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients 39
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study 39
Prognostic Role of Malnutrition Diagnosed by Bioelectrical Impedance Vector Analysis in Older Adults Hospitalized with COVID-19 Pneumonia: A Prospective Study 39
One Word to Describe My Experience as a COVID-19 Survivor Six Months after Its Onset: Findings of a Qualitative Study 38
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study 38
Unusual forms of subacute invasive pulmonary aspergillosis in patients with solid tumors 38
Treatment of Infections Due to MDR Gram-Negative Bacteria 38
Multidrug-resistant Gram-negative bacteria-resistant infections: epidemiology, clinical issues and therapeutic options 38
Prevalence of colorectal disease in Enterococcus faecalis infective endocarditis: results of an observational multicenter study 38
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis 37
COVID-19 positive donor for solid organ transplantation 37
The safety of treatment options for acute bacterial skin and skin structure infections 37
Daptomycin-containing regimens for treatment of Gram-positive endocarditis 37
Effects of Immunocompromise and Comorbidities on Pneumococcal Serotypes Causing Invasive Respiratory Infection in Adults: Implications for Vaccine Strategies 37
Cystic dystrophy of the pancreas in patient with only one previous cyst 37
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae? 37
What Kind of Interventions Were Perceived as Effective Against Coronavirus-19 in Nursing Homes in Italy? A Descriptive Qualitative Study 36
Estimated burden of fungal infections in Italy 36
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country 36
Improving management and antimicrobial stewardship for bacterial and fungal infections in hospitalized patients with COVID-19 36
The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery 35
Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance 35
Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia 35
The management of multidrug-resistant Enterobacteriaceae 35
New antibiotics for ventilator-associated pneumonia 35
Important new therapies for methicillin-resistant Staphylococcus aureus 35
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study) 34
The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia 34
The role of dalbavancin in skin and soft tissue infections 34
Filamentous fungal infections in immunosuppressed patients: prophylaxis and treatment 34
Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction 34
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia 33
Recent concepts in fungal involvement in skin and soft tissue infections 33
Longest incubation period of Mycobacterium chimaera infection after cardiac surgery 32
Higher levels of IL-6 early after tocilizumab distinguish survivors from nonsurvivors in COVID-19 pneumonia: A possible indication for deeper targeting of IL-6 32
Gram-negative bacteria as a cause of mediastinitis after cardiac surgery 31
Italian epidemiology of Gram negative bloodstream infections over 4-year period 30
The burden of severe cases of Influenza disease: the Friuli Venezia Giulia Region experience 27
Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis 27
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, non-neutropenic, adult patients: An update including COVID-19 data 26
Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge 25
Risk Factors for Candidemia After Open Heart Surgery: Results From a Multicenter Case-Control Study 24
Mental health symptoms one year after acute COVID-19 infection: prevalence and risk factors : [síntomas de salud mental un año después de la infección aguda por COVID-19: prevalencia y factores de riesgo] 22
Totale 4.073
Categoria #
all - tutte 38.430
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.430


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 0 0 0 0 0 2 1 1 0 6 0 2
2020/202164 1 9 1 4 1 6 5 5 6 4 4 18
2021/2022219 0 1 0 1 2 2 0 0 112 22 2 77
2022/2023628 48 3 7 75 44 209 2 85 94 29 16 16
2023/20242.797 386 446 421 537 610 200 35 47 45 17 11 42
2024/2025505 7 39 323 81 55 0 0 0 0 0 0 0
Totale 4.229